By Callum Mercer
There is a particular kind of pharmaceutical advertisement — you’ve seen it, everyone has seen it, it is inescapable as a bus shelter and approximately as informative — where the first thirty seconds shows a middle-aged couple bicycling through an autumnal meadow while a voice-over explains, in the brisk, administrative tone of someone reading a shipping manifest, that the drug being advertised may cause dizziness, nausea, liver damage, suicidal ideation, and in rare cases, death. Then the music swells. The couple arrives somewhere nice. Ask your doctor if Getwellbutol is right for you. The FDA approved this. The commercial was approved, the drug was approved, the particular arrangement of side effects deemed acceptable for a product sold to ordinary people with back pain — all of it, approved — By the United States Food and Drug Administration, the federal agency responsible for protecting the public health by ensuring the safety, efficacy, and security of human drugs. That is the agency’s stated mandate, available on its website, written in the earnest and unambiguous language of civic purpose. What the website does not mention is that a substantial number of the people making those approval decisions spent their careers in the pharmaceutical industry, and a substantial number will return to it when the time is right. That the revolving door between regulator and regulated spins so reliably, so constantly, so frictionlessly, that one begins to suspect it wasn’t installed by accident. One begins to suspect it was load-bearing.
This is regulatory capture. Not a conspiracy theory. A documented, named, academically studied phenomenon with a fifty-year literature behind it, a Wikipedia page that could use some attention, and a quiet, unremarkable presence in the daily operations of nearly every major federal agency in the United States. The term comes from economist George Stigler, who in 1971 published the then-radical suggestion that regulatory agencies, over time, tend to be controlled by the industries they were created to regulate. This was considered a provocative insight at the time. It is now considered a description of Tuesday.
What Regulatory Capture Is — And Why No One Talks About It
The mechanics are not glamorous. This is, in fact, part of the problem. Regulatory capture doesn’t look like a crime. There’s no envelope of cash, no parking-garage informant, no third act where the villain delivers a monologue. What it looks like is a LinkedIn profile. It looks like a man who spent fourteen years at a major pharmaceutical company being appointed to a senior position at the FDA’s drug review division. It looks like a woman who spent a decade shaping federal telecommunications policy at the FCC departing, eighteen months later, for a senior vice presidency at the company she had just finished overseeing. It looks like the SEC’s enforcement division staffed, at its upper tiers, with alumni of the very banks and hedge funds that periodically require enforcing against — alumni who know, from intimate professional experience, how to identify the kind of enforcement action that will merely sting versus the kind that will actually change behaviour, and who have colleagues, mentors, and future employers on the other side of the table.
And this is the part that rewards careful attention: the mechanism doesn’t require bad actors. It doesn’t require anyone to take a meeting they shouldn’t take, or sign something they know they shouldn’t sign, or even think a thought they’d be embarrassed to have read aloud. It requires only that human beings — ambitious, professionally socialized, financially motivated human beings who have spent the better part of a career inside a particular industry — carry that industry’s assumptions, instincts, and definitions of “reasonable” with them when they cross the hall into public service. The pharmaceutical executive who becomes an FDA reviewer doesn’t need to be corrupt to find aggressive drug safety enforcement vaguely excessive. The telecom insider who joins the FCC doesn’t need a secret arrangement to find net neutrality regulation instinctively heavy-handed. They just need to be, in the most ordinary and forgivable human sense, the product of where they’ve been. Regulatory capture runs not on venality but on professional formation — on the fact that twenty years inside an industry is an education, and educations leave marks, and the marks are precisely what the industry was counting on when the appointment was made.
It looks entirely normal. It is entirely normal. That is precisely the point.
The Revolving Door Between Industry and Government: How Regulatory Capture Actually Works
The revolving door between industry and government is not merely metaphor. It is infrastructure. And like most infrastructure, we’ve stopped seeing it. We walk through it twice a day, back and forth, industry to government to industry, and we’ve come to experience its frictionlessness as evidence of a well-functioning system rather than evidence of a system that has been, in the technical and entirely accurate sense of the phrase, captured. The watchdog, in other words, ends up on the industry’s leash. Not because anyone broke the law. Not because of some dramatic, cinematic corruption. But because the leash was built into the kennel’s original design, and we have spent several decades calling it a safety feature.
Captured is the right word. Consider what it implies. The watchdog was supposed to be watching the kennel. At some point — gradually, through a thousand reasonable-seeming individual appointments, through the logic of revolving-door hiring, through the fact that the people who understand the pharmaceutical industry best are the people who have spent their careers inside it — the watchdog ended up wearing the industry’s collar. Nobody made one decisive, villainous decision. The leash was assembled incrementally, politely, through a series of appointments and departures that each looked, in isolation, like sensible personnel management. Collectively, they constituted a structural transfer of power so thorough that the public largely doesn’t register it, and the industry no longer needs to lobby aggressively for outcomes because it has absorbed the body that produces them.
The FCC — the agency that governs who owns what spectrum, what a broadband provider can do to your internet traffic, how large a media conglomerate can legally become — has been led, at various inflection points, by individuals who came directly from the telecom lobby and returned to it. This is not conjecture. It is a matter of public record. The Project on Government Oversight has tracked it. Journalists have documented it so thoroughly that it has ceased to generate much outrage, which is a form of victory for the industries involved. The SEC, which is to Wall Street what a parking enforcement officer is to a city that has quietly abolished parking tickets, spent years watching its enforcement division’s senior staff oscillate between government roles and the firms they were nominally watching, often with a salary differential — industry being considerably more generous than public service — that made the direction of travel fairly predictable. When the SEC eventually imposed financial penalties on major banks following the 2008 collapse, those penalties were, in several notable cases, structured so that the banks could deduct them from their taxes. Someone had to design that outcome. Someone understood both sides of the door well enough to build it.
How Captured Regulatory Agencies Stop Feeling Captured
This is what regulatory capture actually does at scale: it doesn’t bribe the watchdog, it domesticates it. It makes the watchdog feel at home in the kennel. It makes the kennel feel like the obvious, natural, reasonable place to be.
Consider what domestication actually involves. It is not a single event. It is a slow, ambient process — the accumulated weight of lunches and conferences and professional friendships and shared vocabularies and the subtle, unspoken social cost of being the person in the room who asks the uncomfortable question about whether the industry’s preferred outcome might not, in fact, be the public’s preferred outcome. Captured agencies don’t become captured overnight and they don’t become captured through explicit instruction. They become captured the way a neighbourhood becomes unaffordable: incrementally, through a thousand individually unremarkable decisions, until one day you look around and notice that everyone who used to push back has either left or stopped pushing, and the people who replaced them grew up thinking this was just what the neighbourhood looked like. The institutional memory of what the watchdog was originally supposed to be doing gets thinner with every personnel cycle, every rotating appointment, every cohort of new staff trained by the cohort that came before them — who were trained, in turn, inside the very industry they were hired to watch.
What’s left, eventually, is an agency that still speaks the language of public protection with complete sincerity, still publishes its mission statement, still processes its comment periods and issues its rulings — but whose collective sense of what constitutes a serious problem, an aggressive enforcement, an acceptable risk, has been quietly, patiently, professionally realigned. The kennel didn’t change the lock on the door. It changed what the watchdog dreams about. And if you ask the watchdog, it will tell you, without any guile whatsoever, that it is doing an excellent job.
The “We Need Industry Expertise” Argument — And Why It’s Part of the Problem
Here is where someone usually intervenes with the sensible objection: but we need industry expertise. Regulators need to understand the pharmaceutical industry to regulate pharmaceuticals. You can’t staff the SEC with people who’ve never touched a balance sheet. You can’t run telecommunications policy from a position of principled ignorance about how telecommunications actually functions. And this is true, and it is also — notice how smoothly this argument moves, how closely it resembles a reasonable observation — precisely the thing the industry would very much like you to believe, because it provides the ideological foundation for the entire revolving-door arrangement. The argument for why the watchdog must be trained by the kennel is, structurally, the same argument the kennel deploys to maintain control of the watchdog.
There is a real difference between regulatory expertise and regulatory capture. The former requires understanding an industry deeply enough to hold it accountable. The latter requires that understanding to be structured so that the industry’s preferences, over time, become the regulator’s instincts — so that what the industry considers “aggressive enforcement” begins to feel, to the regulator, like radicalism or naivety, while what the industry considers an acceptable outcome feels like pragmatism.
Regulatory capture doesn’t demand that individual regulators be corrupt. It only requires that they be deeply, professionally, socially embedded in a world where a certain kind of outcome feels natural and a certain kind of enforcement feels like a misunderstanding of how things actually work. The pharmaceutical industry calls aggressive drug safety enforcement “innovation-limiting.” The telecom industry calls net neutrality enforcement “regulatory overreach.” Wall Street calls capital requirements “impediments to market function.” These are lobby positions when they come from a lobbyist. Repeated in enough conference rooms, across enough career trajectories, by enough people who move between the industry and its regulator and back again, they become something else. They become institutional common sense. They become the water everyone is swimming in, with no one left in the building who remembers a time before the water was there.
Regulatory Capture Has Been Documented for 50 Years. So Why Does It Keep Happening?
Here is the thing that should give us pause — those of us who have absorbed the comfortable belief that transparency alone is sufficient: regulatory capture has been thoroughly, repeatedly, exhaustively exposed. For fifty years. Stigler’s paper was published in 1971. The revolving door has been documented so extensively that entire journalism beats exist to cover it, watchdog websites track it, and academic journals are dedicated to its study. Regulatory capture is not a secret. It is not a suppressed truth. It is, in a very real and slightly dispiriting sense, public knowledge. We are not waiting to learn about it. We have learned about it, absorbed it, filed it in the cognitive drawer labelled depressing things that are nonetheless legal, and returned to the meadow in the pharmaceutical commercial.
This is, arguably, regulatory capture’s most impressive structural achievement. Most concentrations of power require some degree of concealment to sustain themselves. Regulatory capture requires almost none. It has been named, mapped, documented, and peer-reviewed. The watchdog wears a leash in plain sight. The leash-holder has a business card with both addresses on it — the federal agency and the industry association — and hasn’t technically done anything wrong. Call that a conspiracy and a federal judge will look at you with the patient expression of someone who has heard this before and explain, not unkindly, that a conspiracy requires illegal activity. What we have here is legal activity that produces the outcomes a conspiracy would, arranged without the legal risk, and funded primarily by the industry it benefits.
We call this the system working as intended. And in a clarifying, rather bleak way, it is.
Who Regulatory Capture Really Serves — And What We’re Choosing Not to Do About It
None of which absolves the rest of us. We are in the room when the silence falls, and the silence has been falling for a while. We elected the legislators who confirmed the appointments. We watched the Senate confirmation hearings where nominees answered every question about their former employers with the careful, practiced non-specificity of someone who knows they will, shortly, have former employers again. We filed it under depressing and moved on, because regulatory capture is relentlessly, deliberately boring — because bureaucratic capture is conducted in the register of personnel decisions and comment periods and administrative law, which is to civic engagement what a dental waiting room is to entertainment.
Exhaustion is the most underrated political force in modern life. More dependable than corruption. Cheaper than lobbying. And entirely self-generating. We are tired. The industry is not tired. The industry has whole departments dedicated to not being tired, staffed by people who used to work at the agency they’re now influencing and who will, in two or three years, work there again. The leash stays on. The door keeps spinning. And somewhere in an office building near a federal campus, the next appointment is being processed — the résumé is being reviewed, the qualifications are being assessed, and the watchdog is learning the kennel’s routines, eating the kennel’s food, and beginning, quite sincerely, to see things from the kennel’s perspective.
The question isn’t when we’re going to discover that regulatory capture is happening. We know. The question — the one that sits in the back of the room, asking for recognition — is whether we’ve decided, collectively and more or less consciously, that a leash we can see is somehow better than one we can’t. That visibility is a substitute for accountability. That knowing about a system and changing a system are, in some important sense, the same thing.
They are not. And we know that too.
Further Reading:
- George Stigler, “The Theory of Economic Regulation”, Bell Journal of Economics and Management Science, 1971 — the foundational paper that named and defined regulatory capture as a field of serious study.
- James Q. Wilson, The Politics of Regulation (Basic Books, 1980) — an essential examination of how regulatory agencies evolve and who ultimately controls them.
- The Revolving Door Project tracks industry-to-government appointments and departures in real time, and their database is both publicly available and genuinely instructive.
- The Project on Government Oversight (POGO) maintains ongoing documentation of conflicts of interest across federal agencies: pogo.org
- David Dayen, Monopolized: Life in the Age of Corporate Power (The New Press, 2020) — on how captured regulators enabled the consolidation of industry across nearly every sector of American economic life.
